Go Back   NeuroTalk Support Groups > General > Health News Headlines

Health News Headlines News and research in health, neurology and mental health.

Votrient Approved to Treat Cancer That Begins in Soft Tissue (Yahoo)

Closed Thread
Thread Tools Display Modes
Unread 04-27-2012, 03:40 PM   #1
NewsBot
News Gatherer
Community Support Team
 
Join Date: Dec 2007
Posts: 45,709
My Mood:
Default Votrient Approved to Treat Cancer That Begins in Soft Tissue (Yahoo)

FRIDAY, April 27 (HealthDay News) -- Votrient (pazopanib) has been approved by the U.S. Food and Drug Administration to treat people with soft tissue sarcoma that have received previous chemotherapy.

Read the full article...

(From Yahoo Diseases)
NewsBot is offline  
Closed Thread

Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off
Forum Jump

Similar Threads
Thread Thread Starter Forum Replies Last Post
FDA approves Glaxo cancer drug Votrient (Yahoo) NewsBot Health News Headlines 0 04-26-2012 09:10 PM
Drug approved to treat cystic fibrosis' root cause (AP) (Yahoo) NewsBot Health News Headlines 0 01-31-2012 02:30 PM
Soft Tissue Nerve Impingement (muscle, not spinal) axseptants Peripheral Neuropathy 2 05-16-2011 07:04 AM
Votrient Approved for Advanced Kidney Cancer (HealthDay) (Yahoo) NewsBot Health News Headlines 0 10-20-2009 11:10 PM
Votrient Approved for Advanced Kidney Cancer (HealthDay) (Yahoo) NewsBot Health News Headlines 0 10-20-2009 05:00 PM


All times are GMT -5. The time now is 06:34 PM.
Brought to you by the fine folks who publish mental health and psychology information at Psych Central Mental Health Forums

The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment
provided by a qualified health care provider. Always consult your doctor before trying anything you read here.


Powered by vBulletin • Copyright ©2000 - 2014, Jelsoft Enterprises Ltd.


All posts copyright their original authors Community Guidelines Terms of Use Privacy Policy
NeuroTalk Archives